Future Health
Future health portfolio identifies attractive investment opportunities arising from increasing demands for healthcare, aging populations, changing lifestyles, wealth effects in emerging economies, and innovation in health sector.
Investment Strategy Objective
The strategy is a pure-play allocation seeking attractive risk-adjusted return opportunities primarily in these areas:
- Innovation in the production of new medicines and biotech-generics
- Modernization of equipment and services
- Development of more effective tools and technology
Impact Objective
The strategy targets improvement in preserving, restoring, and financing health, while increasing access to high-quality healthcare and health security.
Allocation: algorithmic passive
Strategy: thematic pure play
Asset class: equity
Geography: global (or define)
Market capitalization: calculate
Median market cap per company: calculate (median over the past year)
Performance Metrics
Top Holdings
wdt_ID | Name | Ticker | Industry | Market Cap last EOY (US$ mn) |
---|---|---|---|---|
1 | UnitedHealth Group Incorporated | UNH | Healthcare | 488,466 |
2 | Eli Lilly and Company | LLY | Healthcare | 318,337 |
3 | Thermo Fisher Scientific Inc. | TMO | Healthcare | 205,667 |
4 | AstraZeneca PLC | AZN | Healthcare | 172,645 |
5 | Bristol-Myers Squibb Company | BMY | Healthcare | 152,531 |
6 | Gilead Sciences, Inc. | GILD | Healthcare | 83,855 |
7 | Regeneron Pharmaceuticals, Inc. | REGN | Healthcare | 77,467 |
8 | Vertex Pharmaceuticals Incorporated | VRTX | Healthcare | 77,024 |
9 | Intuitive Surgical, Inc. | ISRG | Healthcare | 68,461 |
10 | Boston Scientific Corporation | BSX | Healthcare | 58,811 |